Ensifentrine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ensifentrine. Educational only — not medical advice.
Labeled uses
OHTUVAYRE is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.
Source: FDA labeling via NIH DailyMed (set e6433c98…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.